Huntington National Bank boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,490 shares of the medical equipment provider’s stock after buying an additional 271 shares during the quarter. Huntington National Bank’s holdings in Intuitive Surgical were worth $3,504,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently modified their holdings of ISRG. Nuveen Asset Management LLC boosted its stake in Intuitive Surgical by 32,872.7% in the second quarter. Nuveen Asset Management LLC now owns 1,847,791 shares of the medical equipment provider’s stock worth $969,259,000 after buying an additional 1,842,187 shares in the last quarter. Morgan Stanley boosted its stake in Intuitive Surgical by 39.1% in the second quarter. Morgan Stanley now owns 4,288,986 shares of the medical equipment provider’s stock worth $2,249,785,000 after buying an additional 1,204,750 shares in the last quarter. Thoroughbred Financial Services LLC boosted its stake in Intuitive Surgical by 101,543.0% in the second quarter. Thoroughbred Financial Services LLC now owns 864,982 shares of the medical equipment provider’s stock worth $86,498,000 after buying an additional 864,131 shares in the last quarter. Coatue Management LLC purchased a new stake in Intuitive Surgical in the second quarter worth approximately $302,483,000. Finally, Vanguard Group Inc. boosted its stake in Intuitive Surgical by 2.0% in the second quarter. Vanguard Group Inc. now owns 8,826,059 shares of the medical equipment provider’s stock worth $4,629,709,000 after buying an additional 169,521 shares in the last quarter. 85.73% of the stock is owned by institutional investors and hedge funds.
ISRG has been the subject of several research reports. Morgan Stanley set a $620.00 target price on Intuitive Surgical and gave the stock a “buy” rating in a research note on Friday, October 18th. UBS Group boosted their price objective on Intuitive Surgical from $560.00 to $590.00 and gave the company a “neutral” rating in a research report on Friday, October 18th. ValuEngine upgraded Intuitive Surgical from a “strong sell” rating to a “sell” rating in a research report on Friday. Royal Bank of Canada set a $570.00 price objective on Intuitive Surgical and gave the company a “hold” rating in a research report on Friday, October 18th. Finally, Piper Jaffray Companies set a $633.00 price objective on Intuitive Surgical and gave the company a “buy” rating in a research report on Friday, October 18th. Three analysts have rated the stock with a sell rating, four have given a hold rating and ten have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $583.00.
In related news, Director Lonnie M. Smith sold 215 shares of the company’s stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $493.18, for a total transaction of $106,033.70. Following the completion of the transaction, the director now owns 330,868 shares in the company, valued at $163,177,480.24. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO Marshall Mohr sold 7,500 shares of the company’s stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $548.43, for a total value of $4,113,225.00. Following the transaction, the chief financial officer now owns 20,135 shares of the company’s stock, valued at approximately $11,042,638.05. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 13,037 shares of company stock valued at $7,105,808. 1.70% of the stock is owned by corporate insiders.
Shares of Intuitive Surgical stock traded down $0.86 during midday trading on Friday, reaching $551.03. 13,602 shares of the company’s stock traded hands, compared to its average volume of 628,809. The company has a market cap of $65.11 billion, a PE ratio of 58.06, a price-to-earnings-growth ratio of 4.07 and a beta of 1.12. The stock has a 50 day moving average of $539.27 and a 200-day moving average of $515.92. Intuitive Surgical, Inc. has a 12 month low of $430.24 and a 12 month high of $589.32.
Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $3.43 EPS for the quarter, beating analysts’ consensus estimates of $2.99 by $0.44. The company had revenue of $1.13 billion during the quarter, compared to the consensus estimate of $1.06 billion. Intuitive Surgical had a return on equity of 18.26% and a net margin of 30.94%. The firm’s revenue for the quarter was up 22.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.83 earnings per share. Research analysts anticipate that Intuitive Surgical, Inc. will post 10.9 EPS for the current year.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Recommended Story: How does a 12b-1 fee affect fund performance?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.